Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.

Henry, D H; Brooks, B J; Case, D C; Fishkin, E; Jacobson, R; Keller, A M; Kugler, J; Moore, J; Silver, R T; Storniolo, A M; Abels, R I; Gordon, D S; Nelson, R; Larholt, K; Bryant, E; Rudnick, S

Henry, D H; Brooks, B J; Case, D C; Fishkin, E; Jacobson, R; Keller, A M; Kugler, J; Moore, J; Silver, R T; Storniolo, A M; Abels, R I; Gordon, D S; Nelson, R; Larholt, K; Bryant, E; Rudnick, S.

Affiliation

Henry DH; Tuttleman Center, Graduate Hospital, Philadelphia, Pennsylvania 19146, USA.

Cancer J Sci Am ; 1(4): 252-60, 1995.

Article de En | MEDLINE | ID: mdl-9166485

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Érythropoïétine / Cisplatine / Anémie / Tumeurs / Antinéoplasiques Type d'étude: Clinical_trials / Etiology_studies Aspects: Patient_preference Limites: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: Cancer J Sci Am Sujet du journal: NEOPLASIAS Année: 1995 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links